Evidence map›Paper›PMID 32347525›Full record

ArticleNeotropical entomology2020

A Spinosad-Based Formulation Reduces the Survival and Alters the Behavior of the Stingless Bee Plebeia lucii.

R D Marques, M A P Lima, R D Marques, R C Bernardes

Abstract read
PubMed Publisher
In one paragraph

Article in Neotropical entomology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Exposure ofPathogens (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

R D MarquesDepto de Biologia Animal, Univ. Federal de Viçosa, Viçosa, MG, 36570-900, Brasil.
M A P LimaDepto de Biologia Animal, Univ. Federal de Viçosa, Viçosa, MG, 36570-900, Brasil. maugusta@ufv.br.ORCID http://orcid.org/0000-0002-7044-7671
R D MarquesPrograma de Pós-Graduação em Biologia Animal, Univ. Federal de Viçosa, Viçosa, MG, Brasil.
R C BernardesDepto de Entomologia, Univ. Federal de Viçosa, Viçosa, MG, Brasil.

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior Finance code 001
6 · The paper itself

Abstract

The decline in bee populations worldwide has been associated with the use of pesticides in crop systems where these insects forage. The use of biopesticides, like spinosad, is preferred as an alternative method to control pests, because it is considered safer to non-target insects. In this study, we evaluated the lethal and sublethal effects of the spinosad-based formulation Tracer® on foragers of the stingless bee Plebeia lucii Moure (Apidae: Meliponini). Groups of bees were fed a pure diet (negative control) or a diet at different concentrations of spinosad. Positive control groups consisted of bees orally exposed to a diet with the neonicotinoid imidacloprid. Next, flight behavior, body mass, and respiration rate were evaluated in surviving bees. The results showed that bees´ survival was reduced by all concentrations of spinosad, when compared with the negative control. Bee locomotion-walking and flight-was reduced in accordance with the increase in spinosad concentrations; however, body mass and respiration rate were not altered. Our results show that the use of Tracer® in ecosystems visited by P. lucii can reduce forager bee survival and reduce their locomotion, generating a negative impact on pollination services provided by these bees.

Indexed as

AnimalsBeesBiological Control AgentsBrazilDrug CombinationsFlight, AnimalInsecticidesLocomotionMacrolidesToxicity TestsBiological Control AgentsDrug CombinationsInsecticidesMacrolidesspinosadEcotoxicologyorganic farmingPlebeiapollinator declinespinosad

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.